Gyromitra mushrooms: Difference between revisions

(Text replacement - "Category:Tox" to "Category:Toxicology")
 
(12 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
[[File:Gyromitra_mushrooms.jpg|thumb|Gyromitra mushrooms]]
[[File:Gyromitra_mushrooms.jpg|thumb|Gyromitra mushrooms]]
==Overview==
*Also known as "brain fungi"
*Also known as "brain fungi"
*Fruit in the spring and early summer
*Fruit in the spring and early summer
*Frequently mistaken for morel mushrooms<ref>Brozen R et al. Gyromitra Mushroom Toxicity. Apr 14, 2015. http://emedicine.medscape.com/article/817931-treatment#showall.</ref>
*Frequently mistaken for morel mushrooms<ref>Brozen R et al. Gyromitra Mushroom Toxicity. Apr 14, 2015. http://emedicine.medscape.com/article/817931-treatment#showall.</ref>
*Inhibits formation of Vitamin B6 and GABA via hydrazine metabolite
*Inhibits formation of Vitamin B6 and GABA via hydrazine metabolite (similar to [[INH toxicity|isoniazid toxicity]])


==Clinical findings==
==Clinical Features==
*GI upset, fatigue, muscle cramps
*GI upset, fatigue, muscle cramps
*Can present with refractory seizures due to GABA deficiency
*[[Liver failure]]
*[[Hypoglycemia]]
*[[Rhabdomyolysis]]
*Can present with refractory [[seizures]] due to GABA deficiency
*Hemolysis usually mild
*Hemolysis usually mild
*Rarely methemoglobinemia
*Rarely [[methemoglobinemia]]


==Management==
==Differential Diagnosis==
{{Mushroom toxicity DDX}}
 
==Evaluation==
===Workup<ref>Tomková J, Ondra P, Válka I. Simultaneous determination of mushroom toxins α-amanitin, β-amanitin and muscarine in human urine by solid-phase extraction and ultra-high-performance liquid chromatography coupled with ultra-high-resolution TOF mass spectrometry. Forensic Sci Int. 2015 Jun. 251:209-13.</ref>===
*Blood sugar
*BMP
*LFT
*Coags
*CBC with differential
*LDH, haptoglobin, reticulocyte
*CK
*MetHb level
*Urine drug screen
*[[Urinalysis]]
 
==Management<ref>Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. 2005 Feb. 33(2):427-36.</ref>==
*Supportive care
*Supportive care
*High dose pyridoxine for refractory seizures (5g IV initially)
*[[Dextrose]] boluses/infusions
*Avoid phenobarbital, especially in liver failure
*High dose [[pyridoxine]] for refractory seizures (5g IV initially) <ref> Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. 2005;28(2):175. </ref>
*Methylene blue for severe methemoglobinemia
*Avoid [[phenobarbital]], especially in liver failure
*Folinic acid supplementation (hydrazines inhibit MTHF production)
*[[Methylene blue]] for severe methemoglobinemia
*Folinic acid ([[leucovorin]]) supplementation (hydrazines inhibit MTHF production)
*Liver transplant for refractory hepatic failure
 
==Disposition==


==See Also==
==See Also==

Latest revision as of 15:37, 8 February 2021

Background

Gyromitra mushrooms
  • Also known as "brain fungi"
  • Fruit in the spring and early summer
  • Frequently mistaken for morel mushrooms[1]
  • Inhibits formation of Vitamin B6 and GABA via hydrazine metabolite (similar to isoniazid toxicity)

Clinical Features

Differential Diagnosis

Mushroom toxicity by Type

Mushroom Toxin Pathologic Effect
Amanita Amatoxin Hepatotoxicity
Coprine Disulfiram-like
Crotinarius Orellanine Delayed renal failure
Gyromitra Gyromitrin Seizures
Ibotenic Acid Anticholinergic
Muscarine Cholinergic
Orellanin Nephrotoxicity
Psilocybin Hallucinations

Evaluation

Workup[2]

  • Blood sugar
  • BMP
  • LFT
  • Coags
  • CBC with differential
  • LDH, haptoglobin, reticulocyte
  • CK
  • MetHb level
  • Urine drug screen
  • Urinalysis

Management[3]

  • Supportive care
  • Dextrose boluses/infusions
  • High dose pyridoxine for refractory seizures (5g IV initially) [4]
  • Avoid phenobarbital, especially in liver failure
  • Methylene blue for severe methemoglobinemia
  • Folinic acid (leucovorin) supplementation (hydrazines inhibit MTHF production)
  • Liver transplant for refractory hepatic failure

Disposition

See Also

References

  1. Brozen R et al. Gyromitra Mushroom Toxicity. Apr 14, 2015. http://emedicine.medscape.com/article/817931-treatment#showall.
  2. Tomková J, Ondra P, Válka I. Simultaneous determination of mushroom toxins α-amanitin, β-amanitin and muscarine in human urine by solid-phase extraction and ultra-high-performance liquid chromatography coupled with ultra-high-resolution TOF mass spectrometry. Forensic Sci Int. 2015 Jun. 251:209-13.
  3. Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. 2005 Feb. 33(2):427-36.
  4. Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. 2005;28(2):175.